Universitat de Girona > Directori > Pàgina personal
Anar al contingut (clic a Intro)
UdG Home UdG Home
Tancar
Menú

Dra.  Piñol Sanchez, Virginia

Plana personal

Piñol Sanchez, Virginia
Categoria
PROFESSORA AGREGADA
Departament
CIÈNCIES MÈDIQUES
Àrea de coneixement
MEDICINA
ORCID PRC:
0000-0003-3669-6989

Currículum abreujat

  1. Piñol V, Bessa X, Bruguera M, Rodés J. Esteatosis y esteatohepatitis no alcohólica. Análisis comparativo. Gastroenterol Hepatol 2000; 23:57-61.
  2. Ciclooxigenasa-2 (COX-2) en el cancer digestivo. Implicaciones terapeuticas. Bessa, X; Pinol, V; Elizalde, J I; et al. Gastroenterol Hepatol 2000; 23:483-90.
  3. Bessa X, Elizalde JI, Boix L, Piñol V, Lacy AM, Saló J, Piqué JM, Castells A. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 2001; 120:1084-1092.
  4. Bessa X, Castells A, Lacy AM, Elizalde JI, Delgado S, Boix L, Piñol V, Pellisé M, García-Valdecasas JC, Piqué JM. Laparoscopic-assisted versus open colectomy for colorectal cancer: influence on neoplastic cell mobilization. J Gastrointest Surg 2001; 5:66-73.
  5. Bessa X, Elizalde JI, Mitjans JI, Piñol V, Miquel R, Panés J, Piulats J, Piqué JM, Castells A. Leukocyte recruitment in colorectal cancer: role of cell adhesion molecules, nitric oxide and transforming growth factor-b Gastroenterology 2002; 122:1122-1132.
  6. Papel de la ultrasonografia endoscopica en las estrategias diagnostico-terapeuticas en oncologia digestiva. [Role of echoendoscopy in diagnostic and  therapeutic strategies in gastrointestinal oncology].  Elizalde, J I; Pinol, V; Bessa, X; et al. Gastroenterologia y hepatologia 2002; 25: 60-9   
  7. Piñol V, Castells A, Bordas JM, Real MI, Llach J, Montanyà X, Feu F, Navarro S. Randomised clinical trial of percutaneous self-expanding metal stent versus endoscopic polyethylene endoprosthesis for the treatment of malignant biliary obstruction. Radiology 2002;225 :27-34.
  8. Soriano A, Castells A, Lacy AM, Ayuso C, Ayuso JR, Conill C, Delgado S, Fuster J, García-Valdecasas JC, Ginès MA, Martín M, Maurel J, Miquel R, Mollà M, Vilana R, Castellví-Bel S, Elizalde JI, Piñol V, Pellisé M, Biete A, Gascón P, Piqué JM. Evaluación de la eficacia y de la eficiencia de una unidad multidisciplinaria para la atención de los pacientes con cáncer colorrectal. Gastroenterol Hepatol 2002; 25:579-584.S
  9. Bessa X, Piñol V, Castellví-Bel S, Piazuelo E, Lacy AM, Elizalde JI, Piqué JM, Castells A. Prognostic value of postoperative detection of blood circulating tumour cells in patients with colorectal cancer operated on for cure. Ann Surg 2003 ;237(3321) :368-75.
  10. Castellvi-Bel, A Castells, CN Johnstone, V Piñol, M Pellise, JI Elizalde, N Romo, AK Rustgi, JM Pique. Evaluation of g-Parvin Located on 22q13 as a Candidate Tumor Suppressor Gene for Colorectal and Breast Cancer. Cancer Genet Cytogenet 2003; 144, 1: 80-82.
  11. Genomic rearrangements in MSH2 and MLH1 are rare mutational events in Spanish hereditary nonpolyposis colorectal cancer patients. Castellvi-Bel, S; Pinol, V; Mila, M; Pique, JM; Castells, A. American Journmal of Human Genetics 2003;73(5) 231-231.
  12. Ratio of involved to resected lymph nodes and histologic curability predict the prognosis of patients with gastric cancer after curative resection By: Soriano-Izquierdo, A; Castells, A; Pera, M; Pellise, M; Rodriguez-Moranta, F; Fernandez-Esparrach, F; Castellvi-Bell, S ; Pinol, V; Vidal, O; Elizalde, JI; Pique, JM. Gastroenterology 2004; 126(4) A393-A393.
  13. Castells A, Marzo M, Bellas B, Amador FJ, Lanas A, Mascort JJ, Ferrandiz J, Alonso P, Piñol V, Fernandez M, Bonfill X, Pique JM. Clinical guidelines for the prevention of colorectal cancer. Gastroenterol Hepatol 2004;27(10):573-634.
  14. Piñol, M.Andreu, A.Castells, A.Payá, X.Bessa, R.Jover, for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association*. Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain. A multicenter, prospective, nation-wide study. Eur J Gastroenterol Hepatol 2004;16,1:39-45.
  15. Piñol, M. Andreu, A. Castells, A. Payá, X. Bessa, R. Jover, for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors. Diseases of colon and rectum 2004; 47:1192-1200.
  16. Piñol, M.Pagès, A.Castells, P.Bellot, J.Carrión, M.Martín, J. Caballería1, M.C Ayuso, JM. Piqué. Utilidad de la colonografía por tomografía computadorizada para la detección de pólipos colorrectales. Med Clin (Barc) 2004; 123:41-4.
  17. Rodriguez-Moranta F, Castells A, Miquel R, Piñol V, Maurel J, Fuster J, Lacy AM, Pique JM. Late-occurring liver metastases in colorectal cancer. Dig Dis Sci 2005; 50(2):345-7.
  18. Piñol V, Castells A, Andreu M, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Rodríguez-Moranta F, Payá A, Jover R, Bessa X, for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Accuracy of revised Bethesda guidelines, microsatellite instability and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005;293:1986-1994.
  19. Castellví-Bel, A. Castells, M. Strunk, Á. Ferrández, E. Piazuelo, M. Milà, V. Piñol, F. Rodríguez-Moranta, M. Andreu, Á. Lanas, J. M. Piqué and The Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Genomic rearrangements in MSH2 and MLH1 are rare mutational events in Spanish patients with hereditary nonpolyposis colorectal cancer. Cancer Lett. 2005 Jul 8;225(1):93-8
  20. Rodríguez-Moranta F, Saló J, Arcusa A, Boadas J, Piñol V, Bessa X, Batiste-Alentorn E, Lacy AM, Delgado A, Maurel J, Piqué JM, Castells A. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006; 24(3):386-93.
  21. Rodriguez-Moranta, F; Castells, A; Salo, J; Arcusa, A; Boadas, J; Bessa, X; Pinol, V; Balaguer, F ; Cuardrado, R; Delgado, S; Lacy, A; Batiste-Alentorn, E; Pique, JM Efficacy of postoperative surveillance after radical surgery for colorectal cancer (CRC). Analysis of a prospective, multicenter, randomized controlled trial . Gastroenterology 2005; 128 (A566-A566) suppl 2
  22. Llor X, Pons E, Xicola RM, Castells A, Alenda C, Piñol V, Andreu M, Castellví-Bel S, Payá A, Jover R, Bessa X, Girós A, Roca A, Gassull MA for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Differential features of cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 2005; 11(20):7304-10.
  23. Jover R, Zapater P, Castells A, Llor X, Piñol V, Andreu M, Payá A, Alenda C, Xicola RM, Cubiella J, Morillas JD, Bessa X, Clofent J, Bujanda L, Reñé JM, Quintero E, for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 2006; 55(6):848-55.
  24. Rodríguez-Moranta F, Castells A, Andreu M, Piñol V, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Jover R, Payá A, Bessa X, Cubiella J, Argüello L, Morillas JD, Bujanda L, for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Clinical performance of original and revised Bethesda guidelines for the identification of MSH2 / MLH1 gene carriers in patients with newly diagnosed colorectal cancer. Proposal of a new and simpler set of recommendations. Am J Gastroenterol 2006; 101 (5), 1104–1111.
  25. Castells A, Payá A, Alenda C, Rodríguez-Moranta F, Agrelo R, Andreu M, Piñol V, Castellví-Bel S, Jover R, Llor X, Pons E, Elizalde JI, Bessa X, Alcedo J, Saló J, Medina E, Naranjo A, Esteller M, Piqué JM, for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency. Clin Cancer Res 2006;12(6):1686-92.
  26. Bujanda L, Sarasqueta C, Zubiaurre L, Muñoz C, Sanchez A, Martín C, Tito L, Piñol V, Castells A, Llor X, Xicola RM, Pons E, Clofent J, de Castro L, Cuquerella J, Medina E, Gutierrez A, Jover R, Arenas JI, Cosme A. Low adherence to colonoscopy in the screening of first- degree relatives of patients with colorectal cancer. Gut 2007; 56(12):1714-8.
  27. Xicola RM, Llor X, Pons E, Castells A, Alenda C, Piñol V, Andreu M, Castellvi-Bel S, Paya A, Jover R, Bessa X, Giros A, Duque JM, Nicolas-Perez D, Garcia AM, Rigau J, Gassull MA; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst. 2007 Feb 7;99(3):244-5.
  28. Balleste B, Bessa X, Piñol V, Castellvi-Bel S, Castells A, Alenda C, Paya A, Jover R, Xicola RM, Pons E, Llor X, Cordero C, Fernandez-Banares F, de Castro L, Rene JM, Andreu M; For the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Detection of Metachronous Neoplasms in Colorectal Cancer Patients: Identification of Risk Factors. Dis Colon Rectum. 2007; 50(7):971-80.
  29. Antoni Castells, Merce Marzo-Castillejo, Juan Jose Mascort, Francisco Javier Amador, Montserrat Andreu, Begoña Bellas, Angel Ferrandez, Juan Ferrandiz, M.Giraldez, Victoria Gonzalo, Rodrigo Jover, Enrique Quintero, Pablo Alonso-Coello, Xavier Bonfill, Angel Lanas, Virginia Piñol y Josep Pique. Prevención del Cancer Colorrectal. Actualización 2009. Gastroenterol Hepatol.2009; 32(10) :717.e1-e58.
  30. Gonzalo V, Lozano JJ, Muñoz J, Balaguer F, Pellisé M, Rodríguez de Miguel C, Andreu M, Jover R, Llor X, Giráldez MD, Ocaña T, Serradesanferm A, Alonso-Espinaco V, Jimeno M, Cuatrecasas M, Sendino O, Castellví-Bel S, Castells A; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer.PLoS One. 2010 Jan 19;5(1):e8777
  31. Abulí A, Bessa X, González JR, Ruiz-Ponte C, Cáceres A, Muñoz J, Gonzalo V, Balaguer F, Fernández-Rozadilla C, González D, de Castro L, Clofent J, Bujanda L, Cubiella J, Reñé JM, Morillas JD, Lanas A, Rigau J, García AM, Latorre M, Saló J, Fernández Bañares F, Argüello L, Peña E, Vilella A, Riestra S, Carreño R, Paya A, Alenda C, Xicola RM, Doyle BJ, Jover R, Llor X, Carracedo A, Castells A, Castellví-Bel S, Andreu M; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype. 2010 Sep;139(3):788-96, 796.e1-6. Epub 2010 Jun 2.
  32. Bujanda L, Sarasqueta C, Hijona E, Hijona L, Cosme A, Gil I, Elorza JL, Asensio JI, Larburu S, Enríquez-Navascués JM, Jover R, Balaguer F, Llor X, Bessa X, Andreu M, Paya A, Castells A; Collaborators: Morillas JD, Muñoz R, Manzano M, Colina F, Díaz J, Ibarrola C, López G, Ibáñez A, Castells A, Piñol Colorectal cancer prognosis twenty years later. Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. World J Gastroenterol. 2010 Feb 21;16(7):862-7.
  33. Abulí A, Fernández-Rozadilla C, Alonso-Espinaco V, Muñoz J, Gonzalo V, Bessa X, González D, Clofent J, Cubiella J, Morillas JD, Rigau J, Latorre M, Fernández-Bañares F, Peña E, Riestra S, Payá A, Jover R, Xicola RM, Llor X, Carvajal-Carmona L, Villanueva CM, Moreno V, Piqué JM, Carracedo A, Castells A, Andreu M, Ruiz-Ponte C, Castellví-Bel S; for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins. BMC Cancer.2011 Aug 5;11(1):339.
  34. Pérez-Carbonell L, Ruiz-Ponte C, Guarinos C, Alenda C, Payá A, Brea A, Egoavil CM, Castillejo A, Barberá VM, Bessa X, Xicola RM, Rodríguez-Soler M, Sánchez-Fortún C, Acame N, Castellví-Bel S, Piñol V, Balaguer F, Bujanda L, De-Castro ML, Llor X, Andreu M, Carracedo A, Soto JL, Castells A, Jover R. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Gut. 2012 Jun;61(6):865-72. doi: 10.1136/gutjnl-2011-300041. Epub 2011 Aug 25
  35. Castellví-Bel S, Ruiz-Ponte C, Fernández-Rozadilla C, Abulí A, Muñoz J, Bessa X, Brea-Fernández A, Ferro M, Giráldez MD, Xicola RM, Llor X, Jover R, Piqué JM, Andreu M, Castells A, Carracedo A; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Collaborators: Morillas JD, Muñoz R, Manzano M, Colina F, Díaz J, Ibarrola C, López G, Ibáñez A, Castells A, Piñol Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experience.Mutagenesis.2012Mar;27(2):153-9.doi: 10.1093/mutage/ger047.
  36. Giráldez MD, López-Dóriga A, Bujanda L, Abulí A, Bessa X, Fernández-Rozadilla C, Muñoz J, Cuatrecasas M, Jover R, Xicola RM, Llor X, Piqué JM, Carracedo A, Ruiz-Ponte C, Cosme A, Enríquez-Navascués JM, Moreno V, Andreu M, Castells A, Balaguer F, Castellví-Bel S; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Susceptibility genetic variants associated with early-onset colorectal cancer. Carcinogenesis. 2012 Mar;33(3):613-9. doi: 10.1093/carcin/bgs009.
  37. Fernandez-Rozadilla C, Cazier JB, Moreno V, Crous-Bou M, Guinó E, Durán G, Lamas MJ, López R, Candamio S, Gallardo E, Paré L, Baiget M, Páez D, López-Fernández LA, Cortejoso L, García MI, Bujanda L, González D, Gonzalo V, Rodrigo L, Reñé JM, Jover R, Brea-Fernández A, Andreu M, Bessa X, Llor X, Xicola R, Palles C, Tomlinson I, Castellví-Bel S, Castells A, Ruiz-Ponte C, Carracedo A; EPICOLON Consortium. Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration. Pharmacogenomics J. 2013 Jun;13(3):209-17. doi: 10.1038/tpj.2012.2. Epub 2012 Feb 7.
  38. Fernandez-Rozadilla C, Palles C, Carvajal-Carmona L, Peterlongo P, Nici C, Veneroni S, Pinheiro M, Teixeira MR, Moreno V, Lamas MJ, Baiget M, Lopez-Fernandez LA, Gonzalez D, Brea-Fernandez A, Clofent J, Bujanda L, Bessa X, Andreu M, Xicola R, Llor X, Jover R; EPICOLON Consortium, Castells A, Castellvi-Bel S, Carracedo A, Tomlinson I, Ruiz-Ponte C. BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern European populations. 2013 Feb;34(2):314-8. doi: 10.1093/carcin/bgs357. Epub 2012 Nov 16.
  39. Picelli S, Lorenzo Bermejo J, Chang-Claude J, Hoffmeister M, Fernández-Rozadilla C, Carracedo A, Castells A, Castellví-Bel S; Memebers of EPICOLON Consortium-Gastrointestinal Oncology Group of the Spanish Gastroenterological Association, Naccarati A, Pardini B, Vodickova L, Müller H, Talseth-Palmer BA, Stibbard G, Peterlongo P, Nici C, Veneroni S, Li L, Casey G, Tenesa A, Farrington SM, Tomlinson I, Moreno V, van Wezel T, Wijnen J, Dunlop M, Radice P, Scott RJ, Vodicka P, Ruiz-Ponte C, Brenner H, Buch S, Völzke H, Hampe J, Schafmayer C, Lindblom Meta-analysis of mismatch repair polymorphisms within the cogent consortium for colorectal cancer susceptibility.PLoS One. 2013 Sep 6;8(9):e72091. doi: 10.1371/journal.pone.0072091. eCollection 2013
  40. Abulí A, Lozano JJ, Rodríguez-Soler M, Jover R, Bessa X, Muñoz J, Esteban-Jurado C, Fernández-Rozadilla C, Carracedo A, Ruiz-Ponte C, Cubiella J, Balaguer F, Bujanda L, Reñé JM, Clofent J, Morillas JD, Nicolás-Pérez D, Xicola RM, Llor X, Piqué JM, Andreu M, Castells A, Castellví-Bel S; Gastrointestinal Oncology Group of Spanish Gastroenterological Association. Genetic susceptibility variants associated with colorectal cancer prognosis. Carcinogenesis. 2013 Oct;34(10):2286-91. doi: 10.1093/carcin/bgt179. Epub 2013 May 27.
  41. Fernandez-Rozadilla C, Brea-Fernández A, Bessa X, Alvarez-Urturi C, Abulí A, Clofent J, Payá A; EPICOLON Consortium, Jover R, Xicola R, Llor X, Andreu M, Castells A, Carracedo A, Castellví-Bel S, Ruiz-Ponte C. BMPR1A mutations in early-onset colorectal cancer with mismatch repair proficiency.. Clin Genet. 2013 Jul;84(1):94-6. doi: 10.1111/cge.12023. Epub 2012 Oct 12.
  42. Pardini B1, Verderio P2, Pizzamiglio S2, Nici C3, Maiorana MV3, Naccarati A4, Vodickova L5, Vymetalkova V5, Veneroni S6, Daidone MG6, Ravagnani F7, Bianchi T8, Bujanda L9, Carracedo A10, Castells A11, Ruiz-Ponte C10, Morreau H12, Howarth K13, Jones A13, Castellví-Bel S11, Li L14, Tomlinson I13, Van Wezel T12, Vodicka P5, Radice P15, Peterlongo P3; EPICOLON Consortium. Association between CASP8 -652 6N del polymorphism (rs3834129) and colorectal cancer risk: results from a multi-centric study. PLoS One. 2014 Jan 21;9(1):e85538. doi: 10.1371/journal.pone.0085538. eCollection 2014.
  43. Gonzalo V, Lozano JJ, Alonso-Espinaco V, Moreira L, Muñoz J, Pellisé M, Castellví-Bel S, Bessa X, Andreu M, Xicola RM, Llor X, Ruiz-Ponte C, Carracedo A, Jover R, Castells A, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Multiple sporadic colorectal cancers display a unique methylation phenotype. PLoS One. 2014 Mar 18;9(3):e91033. doi: 10.1371/journal.pone.0091033. eCollection 2014
  44. Bellido F, Pineda M, Aiza G, Valdés-Mas R, Navarro M, Puente DA, Pons T, González S, Iglesias S, Darder E, Piñol V, Soto JL, Valencia A, Blanco I, Urioste M, Brunet J, Lázaro C, Capellá G, Puente XS, Valle L. POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Genet Med. 2015 Jul 2. doi: 10.1038/gim.2015.75. [Epub ahead of print
  45. Moreira L, Muñoz J, Cuatrecasas M, Quintanilla I, Leoz ML, Carballal S, Ocaña T, López-Cerón M, Pellise M, Castellví-Bel S, Jover R, Andreu M, Carracedo A, Xicola RM, Llor X, Boland CR, Goel A, Castells A, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer. Cancer. 2015 May 1;121(9):1395-404. doi: 10.1002/cncr.29190. Epub 2014 Dec 29.
  46. Valentín F, Guarinos C, Juárez M, Rodríguez-Soler M, Serradesanferm A, Rodriguez-Moranta F, Nicolas-Perez D, Bujanda L, Herraiz M, De-Castro L, Fernández-Bañares F, Herreros-de-Tejada A, Martínez F, Aguirre E, Ferrández Á, Díaz-Tasende J, Piñol V, Paya A, Egoavil C, Alenda C, Castells A, Jover R, Cubiella J. Endoscopic surveillance in patients with multiple (10?-?100) colorectal polyps. 2015 Jul 10. [Epub ahead of print]
  47. Carballal S, Rodríguez-Alcalde D, Moreira L, Hernández L, Rodríguez L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, López-Cerón M, Cuatrecasas M, López-Vicente J, Leoz ML, Rivero-Sánchez L, Castells A, Pellisé M, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study. Gut. 2015 Aug 11. pii: gutjnl-2015-309647. doi: 10.1136/gutjnl-2015-309647. [Epub ahead of print
  48. Kastrinos F, Ojha RP, Leenen C, Alvero C, Mercado RC, Balmaña J, Valenzuela I, Balaguer F, Green R, Lindor NM, Thibodeau SN, Newcomb P, Win AK, Jenkins M, Buchanan DD, Bertario L, Sala P, Hampel H, Syngal S, Steyerberg EW. Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer. Lynch Syndrome prediction model validation study group. J Natl Cancer Inst. 2015 Nov 18;108(2). pii: djv308. doi: 10.1093/jnci/djv308. Print 2016 Feb
  49. Cubiella J, Vega P, Salve M, Díaz-Ondina M, Alves MT, Quintero E, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Campo R, Bujanda L, Clofent J, Ferrandez Á, Torrealba L, Piñol V, Rodríguez-Alcalde D, Hernández V, Fernández-Seara J; COLONPREDICT study investigators. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.. BMC Med. 2016 Aug 31;14(1):128. doi: 10.1186/s12916-016-0668-5.
  50. Cubiella J, Digby J, Rodríguez-Alonso L, Vega P, Salve M, Díaz-Ondina M, Strachan JA, Mowat C, McDonald PJ, Carey FA, Godber IM, Younes HB, Rodriguez-Moranta F, Quintero E, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Campo R, Bujanda L, Garayoa A, Ferrandez Á, Piñol V, Rodríguez-Alcalde D, Guardiola J, Steele RJ, Fraser CG.The fecal hemoglobin concentration, age and sex test score: development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients. COLONPREDICT study investigators. Int J Cancer. 2017 May 15;140(10):2201-2211. doi: 10.1002/ijc.30639. Epub 2017 Mar 6.
  51. Egoavil C, Juarez M, Guarinos C, Rodríguez-Soler M, Hernández-Illán E, Alenda C, Payá A, Castillejo A, Serradesanferm A, Bujanda L, Fernández-Bañares F, Cubiella J, de-Castro L, Guerra A, Aguirre E, Herreros-de-Tejada A, Bessa X, Herráiz M, Marín-Gabriel JC, Balmaña J, Piñol V, Cuatrecasas M, Balaguer F, Castells A, Soto JL, Zapater P, Jover R. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-degree Relatives. 2017 Jul;153(1):106-112.e2. doi: 10.1053/j.gastro.2017.04.003. Epub 2017 Apr 9.
  52. Quintana I, Mejías-Luque R, Terradas M, Navarro M, Piñol V, Mur P, Belhadj S, Grau E, Darder E, Solanes A, Brunet J, Capellá G, Gerhard M, Valle L. Evidence suggests that germline RNF43 mutations are a rare cause of serrated polyposis. Gut. 2018 Dec;67(12):2230-2232. doi: 10.1136/gutjnl-2017-315733. Epub 2018 Jan 12
  53. Rodríguez-Alcalde D, Carballal S, Moreira L, Hernández L, Rodríguez-Alonso L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, Saperas E, López-Cerón M, Cuatrecasas M, López-Vicente J, Rivero-Sánchez L, Jung G, Vila-Casadesús M, Sánchez A, Castells A, Pellisé M, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome. 2019 Feb;51(2):142-151. doi: 10.1055/a-0656-5557. Epub 2018 Aug 1. PMID: 30068004
  54. Malagón M, Ramió-Pujol S, Serrano M, Serra-Pagès M, Amoedo J, Oliver L, Bahí A, Mas-de-Xaxars T, Torrealba L, Gilabert P, Miquel-Cusachs JO, García-Nimo L, Saló J, Guardiola J, Piñol V, Cubiella J, Castells A, Aldeguer X, Garcia-Gil J. Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers. Aliment Pharmacol Ther. 2019 Jun;49(11):1410-1420. doi: 10.1111/apt.15251. Epub 2019 Apr 25. PMID: 31025420
  55. Belhadj S, Quintana I, Mur P, Munoz-Torres PM, Alonso MH, Navarro M, Terradas M, Piñol V, Brunet J, Moreno V, Lázaro C, Capellá G, Valle L. NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas. Sci Rep. 2019 Jun 21;9(1):9020. doi: 10.1038/s41598-019-45281-1. PMID: 31227763
  56. Dámaso E, Canet-Hermida J, Vargas-Parra G, Velasco À, Marín F, Darder E, Del Valle J, Fernández A, Izquierdo À, Mateu G, Oliveras G, Escribano C, Piñol V, Uchima HI, Soto JL, Hitchins M, Farrés R, Lázaro C, Queralt B, Brunet J, Capellá G, Pineda M. Highly sensitive MLH1 methylation analysis in blood identifies a cancer patient with low-level mosaic MLH1 epimutation. Clin Epigenetics. 2019 Nov 28;11(1):171. doi: 1186/s13148-019-0762-6. PMID: 31779681
  57. Pin-Vieito N, Iglesias MJ, Remedios D, Rodríguez-Alonso L, Rodriguez-Moranta F, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Martínez-Bauer E, Campo R, Bujanda L, Ferrandez Á, Piñol V, Rodríguez-Alcalde D, Guardiola J, Cubiella J, On Behalf Of The Colonpredict Study Investigators. Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test. World J Gastroenterol. 2020 Jan 7;26(1):70-85. doi: 10.3748/wjg.v26.i1.70.
  58. Oliveras B, Albert M, López C, Fort E, Peries L, Gutiérrez L, Busquets D, Uchima H, Aldeguer X, Piñol V. A case report of gastrointestinal histoplasmosis in a patient treated with infliximab. Clin J Gastroenterol. 2020 Nov 24. doi: 10.1007/s12328-020-01298-y. Online ahead of print. PMID: 33231849
  59. Sánchez A, Roos VH, Navarro M, Pineda M, Caballol B, Moreno L, Carballal S, Rodríguez-Alonso L, Ramon Y Cajal T, Llort G, Piñol V, Fernandez AL, Salces I, Picó MD, Rivas L, Bujanda L, Garzon M, Pizarro A, Martinez de Castro E, López-Arias MJ, Poves C, Garau C, Rodriguez-Alcalde D, Herraiz M, Alvarez-Urrutia C, Dacal A, Carrillo-Palau M, Cid L, Ponce M, Barreiro-Alonso E, Saperas E, Aguirre E, Romero C, Bastiaansen B, Gonzalez-Acosta M, Morales-Romero B, Ocaña T, Rivero-Sánchez L, Jung G, Bessa X, Cubiella J, Jover R, Rodríguez-Moranta F, Balmaña J, Brunet J, Castells A, Dekker E, Capella G, Serra-Burriel M, Moreira L, Pellise M, Balaguer F. Quality of colonoscopy is associated with adenoma detection and post-colonoscopy colorectal cancer prevention in Lynch syndrome. Clin Gastroenterol Hepatol. 2020 Nov 3:S1542-3565(20)31514-7. doi: 10.1016/j.cgh.2020.11.002. Online ahead of print
  60. , Ramió-Pujol S, Serrano M, Amoedo J, Oliver L, Bahí A, Miquel-Cusachs JO, Ramirez M, Queralt-Moles X, Gilabert P, Saló J, Guardiola J, Piñol V, Serra-Pagès M, Castells A, Aldeguer X, Garcia-Gil LJ.New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population. PLoS One. 2020 Dec 1;15(12):e0243158. doi: 10.1371/journal.pone.0243158. eCollection 2020. PMID: 332595
  61. Predictive Value of Carcinoembryonic Antigen in Symptomatic Patients without Colorectal Cancer: A Post-Hoc Analysis within the COLONPREDICT Cohort. Pin-Vieito N, Iglesias MJ, Remedios D, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Martínez-Bauer E, Campo R, Bujanda L, Ferrández Á, Piñol V, Rodríguez-Alcalde D, Menéndez-Rodríguez M, García-Morales N, Pérez-Mosquera C, Cubiella J.Diagnostics (Basel). 2020 Dec 2;10(12):E1036. doi: 10.3390/diagnostics10121036

Escull quins tipus de galetes acceptes que el web de la Universitat de Girona pugui guardar en el teu navegador.

Les imprescindibles per facilitar la vostra connexió. No hi ha opció d'inhabilitar-les, atès que són les necessàries pel funcionament del lloc web.

Permeten recordar les vostres opcions (per exemple llengua o regió des de la qual accediu), per tal de proporcionar-vos serveis avançats.

Proporcionen informació estadística i permeten millorar els serveis. Utilitzem cookies de Google Analytics que podeu desactivar instal·lant-vos aquest plugin.

Per a oferir continguts publicitaris relacionats amb els interessos de l'usuari, bé directament, bé per mitjà de tercers (“adservers”). Cal activar-les si vols veure els vídeos de Youtube incrustats en el web de la Universitat de Girona.

La web de Universitat de Girona utilitza galetes pròpies i de tercers amb finalitats tècniques i analítiques. Per administrar-les utilitzi el gestor. Si desitja més informació accedeixi a la Política de galetes.